Skip to main content
. 2015 Feb;20(2):127–132.

Figure 5.

Figure 5

The comparison of the change values of (a) alanine aminotransferase changes; (b) aspartate aminotransferase changes; and (c) total bilirubin from baseline in human immunodeficiency virus (HIV)/hepatitis B virus (HBV)/hepatitis C virus (HCV) co-infected group, HIV/HBV co-infected group, HIV/HCV co-infected group and HIV mono-infected group before and after HAART. *P < 0.01, after highly active antiretroviral therapy (HAART) versus pre-HAART